Advanced glycation end products contribute to the immunogenicity of IFN-β pharmaceuticals

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 3, 2012, Pages

  Bozhinov, Angelina ^a   Handzhiyski, Yordan ^a   Genov, Krasimir ^b   Daskalovska, Vera ^c   Niwa, Toshimitsu ^d   Ivanov, Ivan ^a   Mironova, Roumyana ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Bulgaria)

^b MILITARY MEDICAL ACADEMY   (Bulgaria)

^c SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BETA1A INTERFERON; DRUG ANTIBODY; HUMAN SERUM ALBUMIN; IMIDAZOLONE; IMMUNOGLOBULIN G; INTERFERON ANTIBODY; INTERFERON BETA SERINE; N EPSILON(CARBOXYMETHYL)LYSINE; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; CLINICAL ARTICLE; CROSS REACTION; DRUG DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLU LIKE SYNDROME; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOGENICITY; INJECTION SITE REACTION; LETTER; MULTIPLE SCLEROSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION;

EID: 84857799574     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.10.035     Document Type: Article

References (13)

1. S. Malucchi, A. Sala, F. Gilli, R. Bottero, A. Di Sapio, and M. Capobianco Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis Neurology 62 2004 2031 2037 (Pubitemid 38738217)
2. C. Guijarro, J. Benito-León, and F. Bermejo-Pareja Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis Neurol Sci 32 2011 309 311
3. T. Corona, C. Leon, and L. Ostrosky-Zeichner Severe anaphylaxis with recombinant interferon beta Neurology 52 1999 425 (Pubitemid 29059085)
4. R. Mironova, T. Niwa, R. Dimitrova, M. Boyanova, and I. Ivanov Glycation and post-translational processing of human interferon-gamma expressed in Escherichia coli J Biol Chem 278 2003 51068 51074 (Pubitemid 38020341)
5. R. Mironova, A. Sredovska, I. Ivanov, and T. Niwa Maillard reaction products in the Escherichia coli-derived therapeutic protein interferon alfacon-1 Ann N Y Acad Sci 1126 2008 181 184 (Pubitemid 351589269)
6. B. Liliensiek, M.A. Weigand, A. Bierhaus, W. Nicklas, M. Kasper, and S. Hofer Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response J Clin Invest 113 2004 1641 1650 (Pubitemid 39071688)
7. A. Damasiewicz-Bodzek, and T. Wielkoszyński Advanced protein glycation in psoriasis J Eur Acad Dermatol Venereol 2011 [Epub ahead of print]
8. B. Guo, X. Liang, S.Y. Chung, and S.J. Maleki Proteomic screening points to the potential importance of Ara h 3 basic subunit in allergenicity of peanut Inflamm Allergy Drug Targets 7 2008 163 166
9. P.M. Humpert, I.K. Lukic, S.R. Thorpe, S. Hofer, E.M. Awad, and M. Andrassy AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis J Leukoc Biol 86 2009 589 597
10. T. Niwa, M. Sato, T. Katsuzaki, T. Tomoo, T. Miyazaki, and N. Tatemichi Amyloid b2-microglobulin is modified with N1-(carboxymethyl) lysine in dialysis-related amyloidosis Kidney Int 50 1996 1303 1309 (Pubitemid 26342823)
11. T. Niwa, T. Katsuzaki, S. Miyazaki, T. Momoi, T. Akiba, and T. Miyazaki Amyloid b2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis Kidney Int 51 1997 187 194 (Pubitemid 27064537)
12. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
13. R.A. Reisfeld, U.J. Lewis, and D.E. Williams Disk electrophoresis of basic proteins and peptides on polyacrylamide gels Nature 195 1962 281 283